Glycogen Synthase Kinase 3

Handbook of Cell Signaling: Volume 1-3

Volumn 1-3, Issue , 2003, Pages 547-550

  Cohen, Philip ^a   Frame, Sheelagh ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943252440     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012124546-7/50452-6     Document Type: Chapter

References (39)

1. N. Embi, D.B. Rylatt and P. Cohen (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107 519-527.
2. J.R. Woodgett (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9 2431-2438.
3. S. Frame and P. Cohen (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359 1-16.
4. P. Cohen and S. Frame (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2 769-776.
5. A. Ali, K.P. Hoeflich and J.R. Woodgett (2001) Glycogen synthase kinase-3, properties, functions, and regulation. Chem. Rev. 101 2527-2540.
6. C. Picton, J.R. Woodgett, B. Hemmings and P. Cohen (1982) Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle. Phosphorylation of site 5 by glycogen synthase kinase-5 (casein kinase-II) is a prerequisite for phosphorylation of sites 3 by glycogen synthase kinase-3. FEBS Lett. 150 191-196.
7. C.J. Fiol, et al. (1987) Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J. Biol. Chem. 262 14042-14048.
8. G.I. Welsh and C.G. Proud (1993) Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 294 625-629.
9. G.I. Welsh, et al. (1998) Regulation of eukaryotic initiation factor eIF2B, glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 421 125-130.
10. Y.L. Woods, et al. (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem. J. 355 609-615.
11. K. Hughes, et al. (1992) Identification of multifunctional ATP-citrate lyase kinase as the α-isoform of glycogen synthase kinase-3. Biochem. J. 288 309-314.
12. W.B. Benjamin, et al. (1994) ATP citrate-lyase and glycogen synthase kinase-3β in 3T3-L1 cells during differentiation into adipocytes. Biochem. J. 300 477-482.
13. C.J. Fiol, et al. (1994) A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J. Biol. Chem. 269 32187-32193.
14. S. Frame, P. Cohen and R.M. Biondi (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell. 7 1321-1327.
15. E. ter Haar, et al. (2001) Structure of GSK3β reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8 593-596.
16. R. Dajani, et al. (2001) Crystal structure of glycogen synthase kinase 3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell. 105 721-732.
17. K. Hughes, et al. (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12 803-808.
18. M. Shaw, P. Cohen and D.R. Alessi (1997) Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 416 307-311.
19. L. Kim, J. Liu and A.R. Kimmel (1999) The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification. Cell 99 399-408.
20. R.V. Bhat, et al. (2000) Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. USA 97 11074-11079.
21. J.A. Hartigan and G.V. Johnson (1999) Transient increases in intracellular calcium result in prolonged site-selective increases in tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway. J. Biol. Chem. 274 21395-21401.
22. D.A. Cross, et al. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 785-789.
23. V. Stambolic and J.R. Woodgett (1994) Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochem. J. 303 701-704.
24. M. Shaw and P. Cohen (1999) Role of protein kinase B and the MAP kinase cascade in mediating the EGF-dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells. FEBS Lett. 461 120-124.
25. J.L. Armstrong, et al. (2001) Regulation of glycogen synthesis by amino acids in cultured human muscle cells. J. Biol. Chem. 276 952-956.
26. M.R. Williams, et al. (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10 439-448.
27. P.J. Parker, F.B. Caudwell and P. Cohen (1983) Glycogen synthase from rabbit skeletal muscle: effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur. J. Biochem. 130 227-234.
28. H. Eldar-Finkelman, et al. (1999) Increased glycogen synthase kinase-3 activity in diabetes- and obesity- prone C57BL/6J mice. Diabetes. 48 1662-1666.
29. M.P. Coghlan, et al. (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7 793-803.
30. P. Norman (2001) Emerging fundamental themes in modern medicinal chemistry. Drug News Perspect. 14 242-247.
31. P.A. Lochhead, et al. (2001) Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphoenolpyruvate carbokykinase gene expression. Diabetes. 50 937-946.
32. D.A. Cross, et al. (2001) Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J. Neurochem. 77 94-102.
33. T.C. Dale (1998) Signal transduction by the Wnt family of ligands. Biochem. J. 329 209-223.
34. L. Li, et al. (1999) Axin and Frat1 interact with dv1 and GSK, bridging Dv1 to GSK in Wnt-mediated regulation of LEF-1. EMBO J. 18 4233-4240.
35. G.M. Thomas, et al. (1999) A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and β-catenin. FEBS Lett. 458 247-251.
36. G.H.R. Farr, et al. (2000) Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J. Cell Biol. 148 691-702.
37. K.P. Hoeflich, et al. (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406 86-90.
38. P. Polakis (2000) Wnt signaling and cancer. Genes Dev. 14 1837-1851.
39. E. Fraser, et al. (2002) Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J. Biol. Chem. 277 2176-2185.